One way to settle the prostate screening debate

Multiparametric magnetic resonance imaging (mpMRI) has the potential to change the diagnosis and treatment of prostate cancer, say two Australian experts.

In an article published in the MJA, Dr Jeremy Grummet and Associate Professor Richard O’Sullivan of Epworth Healthcare in Melbourne point to the “troubling inaccuracy” of the current diagnostic practice of PSA testing and TRUS biopsy.

The poor specificity of PSA for significant prostate cancer is well known, they say, but what may not be common knowledge is that half of